Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating biomarkers in patients with glioblastoma
Juliana Müller Bark, Arutha Kulasinghe, Benjamin Chua, et al.
British Journal of Cancer (2019) Vol. 122, Iss. 3, pp. 295-305
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Prognostic and Predictive Biomarkers in Gliomas
Paulina Śledzińska, Marek Bebyn, Jacek Furtak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10373-10373
Open Access | Times Cited: 244
ctDNA as a cancer biomarker: A broad overview
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer
Critical Reviews in Oncology/Hematology (2020) Vol. 155, pp. 103109-103109
Open Access | Times Cited: 200
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
Elena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1083-1111
Open Access | Times Cited: 116
SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives
Nana Lyu, Amin Hassanzadeh‐Barforoushi, Laura M. Rey Gomez, et al.
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Principles in the Management of Glioblastoma
Domingos Sanchez Roda, Pedro Veiga, Joana Barbosa Melo, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 501-501
Open Access | Times Cited: 16
Detection of circulating tumour cell clusters in human glioblastoma
Ilona Krol, Francesc Castro-Giner, Martina Maurer, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 4, pp. 487-491
Open Access | Times Cited: 114
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 88
Extracellular Vesicles in neural cell interaction and CNS homeostasis
Andrea Schnatz, Christina Müller, Alexandra Brahmer, et al.
FASEB BioAdvances (2021) Vol. 3, Iss. 8, pp. 577-592
Open Access | Times Cited: 74
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy
Kirsten A. White, Kate Connor, Maxime Meylan, et al.
Annals of Oncology (2022) Vol. 34, Iss. 3, pp. 300-314
Open Access | Times Cited: 62
Molecular and Circulating Biomarkers of Brain Tumors
Wojciech Jelski, Barbara Mroczko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7039-7039
Open Access | Times Cited: 61
Emerging SERS biosensors for the analysis of cells and extracellular vesicles
Mohammad Tavakkoli Yaraki, Anastasiia Tukova, Yuling Wang
Nanoscale (2022) Vol. 14, Iss. 41, pp. 15242-15268
Closed Access | Times Cited: 55
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques
Otto Mølby Henriksen, María del Mar Álvarez‐Torres, Patrícia Figueiredo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 52
Liquid Biopsy in Glioblastoma
Lorian Ronvaux, Mattéo Riva, An Coosemans, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3394-3394
Open Access | Times Cited: 43
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
Fang-Ying Chiu, Yun Yen
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 36
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Karan K. Budhraja, Bradon R. McDonald, Michelle D. Stephens, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 678
Open Access | Times Cited: 33
The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis
Siyin Guo, Jing Huang, Genpeng Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
Beatrice Dufrusine, Emily Capone, Sara Ponziani, et al.
Molecular Oncology (2023) Vol. 17, Iss. 8, pp. 1460-1473
Open Access | Times Cited: 22
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges
Attila A. Seyhan
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7974-7974
Open Access | Times Cited: 12
Extracellular vesicles in glioblastoma: a challenge and an opportunity
Vineesh Indira Chandran, Srinivas Gopala, Easwer Hariharan Venkat, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid
Ryosuke Otsuji, Yutaka Fujioka, Nobuhiro Hata, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1009-1009
Open Access | Times Cited: 8
Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 8
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme
Faheem Hyder Pottoo, Md. Noushad Javed, Jawad Ur Rahman, et al.
Seminars in Cancer Biology (2020) Vol. 69, pp. 391-398
Closed Access | Times Cited: 63
Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
Zsuzsanna Birkó, Bálint Nagy, Álmos Klekner, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7522-7522
Open Access | Times Cited: 57
Exosomal noncoding RNAs: key players in glioblastoma drug resistance
Ahmad Movahedpour, Seyyed Hossein Khatami, Marjan Khorsand, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 11, pp. 4081-4092
Closed Access | Times Cited: 44
Page 1 - Next Page

Scroll to top